Avoid Probiotics With Bacillus Licheniformis!

Bacillus licheniformis in fungus-like form. Photo by Milton Wainwright

Many individuals ask me whether they should take probiotics and send me samples of the supplements they are looking at. Some of these probiotics are extremely hazardous and should be avoided. Recent research on cancer tumors using RNA sequencing of organisms identified Bacillus Licheniformis as the pleomorphic organism that has been discussed by scientists since the 19th century. This finding was published in one of the LANCET journals, one of the leading medical publications on the planet.

Rife enthusiasts are still debating about whether Bacillus Licheniformis is the organism Rife identified with his extraordinary microscope in the early 20th century. However, they have no DNA or RNA sequencing evidence to support their arguments. Please realize that DNA/RNA sequencing studies are the gold standard. Microscopes, even one as powerful as the one Rife used, are irrelevant in the face of DNA/RNA evidence.

I keep on moving this item to the top of my web page because people keep asking about the Rife BX, BY "virus" in meetings, telephone calls, voice mail, and email and whether or not to take certain probiotic supplements. 100% of people I have tested with cancer are infected with the Rife organism. Also, 100% of the people I have tested who have taken probiotic supplements containing Bacillus licheniformus have tested positive for Rife organism.

British scientists recently reported in Lancet, that they DNA sequenced the Rife BX, BY "virus". What appears to be the Rife "filterable bacteria" was isolated and each of the various forms of the organism has the DNA sequence of Bacillus licheniformus, a pleomorphic organism that appears as rods, cocci, and fungus-like forms. Rife had a very difficult time culturing this organism in the 1920's and people have had limited success since then, so demonstrating non-contaminated multiple forms of the same organism with exactly the same DNA sequence is a major accomplish that could end decades of controversy.

Sansom, Clare. "Cancer Germ" Bacteria Isolated. THE LANCET Oncology, Vol 4 February 2003, p. 63.
(You will need to create a free Lancet account to view this document.)

"A bacterium from canine mammary tumours which has many similarities to bacteria reported in studies done as far back as the nineteenth century has been isolated by a researcher in the UK.

"The hypothesis that bacteria may be implicated in cancer development has a chequered history. In the late nineteenth and early twentieth centuries, scientists isolated several species of bacteria from tumours, which they believed to cause cancer. By the 1950s, this “cancer germ theory” had fallen completely out of favour; modern interest revolves around the widely studied link between Helicobacter pylori and stomach cancer.

"Milton Wainwright (University of Sheffield, UK) isolated the bacterium on nutrient-free silica gel to reduce contamination. He discovered that the isolate grew in different forms, including short and long rods and cocci. After extended incubation on Czapek-Dox medium, it produced a branched, filamentous form that superficially resembled a fungus. Fungal contamination was initially ruled out by proving that the colony did not respond to non-specific antifungal antibiotics.

“We sent two different forms for 16S RNA sequencing”, says Wainwright. “Not only did we find no contamination, but we found that the forms were identical: they were both Bacillus licheniformis .” Morphological variation within a single bacterial species, or pleomorphism, was recognised as a characteristic of the historical “cancer germ”. Literature reports also describe the “cancer germ” as a Gram positive, non-acid fast, facultative anaerobe: all these are characteristics of B licheniformis."

Milton Wainwright had already published data previously showing bacteria can pass through very small holes (as noted by Rife) and that this has major implications for their role as pathogens. See: Med Hypotheses 2002 Jun;58(6):558-60.

The first step in dealing with cancer electronically must be to eliminate all Bacillus lichenformis from the body as it appears to be both a tumor promoter and a mutagen. Tumors will tend to grow or recur with this organism present. Also, any significant infection with this organism depresses the immune system and severely drains energy from the body, possibly one of the main reasons that newly diagnosed cancer patients often deteriorate so rapidly. Most people with a depressed immune system are infected with nanobacteria and that must be eliminated also. Relevant frequencies are posted elsewhere on this site.

Infected individuals should run this F100 program weekly for as long and as often as it takes to eliminate any detectable Bacillus licheniformis. Multiple treatments will be required as this is a very persistence organism.

An early version of the Rife BX/BY program is below. I have a much more complete and complex version to use with clients that is continually being updated.

label start
dwell 8
duty 10
pulse 64 75
converge 4 1
#Historical Rife freqs BX 21275 BY 20080 B Coli filt virus 17220 B Coli rod form 8020
21275 20080 17220 8020
21113 1675 2008 2127 2663 334 #frequencies from testing multiple individuals
2655 21554 #Lancet article - Bacillus licheniformus fungal form
2385 #Supplement with Bacillus licheniformis
26749 #Supplement with Bacillus licheniformis
425473 #new frequency for another form of the organism
565565 #new frequency for another form of the organism
2521 7356 #new frequency for another form of the organism
16356553 #can only be run with F160 or FSCAN2
86554
535567
dwell 5
converge 0 0
263.11 #stimulate left frontal lobe to enhance immune function
goto start